BridgeBio Pharma Inc banner

BridgeBio Pharma Inc
XBER:2CL

Watchlist Manager
BridgeBio Pharma Inc Logo
BridgeBio Pharma Inc
XBER:2CL
Watchlist
Price: 0.057 EUR Market Closed
Market Cap: €8.4m

Intrinsic Value

2CL price has not been updated for more than 7 years. This may indicate that the stock has been delisted.

The intrinsic value for BridgeBio Pharma Inc (2CL) under the Base Case is 0.045 EUR. Compared with the current market price of 0.057 EUR, the stock appears Overvalued by 21% .

Intrinsic value calculated using Multiples
€0.045

Do our valuations actually work? See backtest results .

2CL Intrinsic Value
0.045
Overvaluation 21%
Intrinsic Value
Price €0.057

Valuation context is not available yet

There is not enough comparable price and intrinsic value history for 2CL.

Monitor 2CL
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €0.04
Get notified when the price drops into your buy zone
Current Price €0.06
Intrinsic Value €0.04
Margin of Safety 20% €0.04
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to 2CL

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

BBIO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one 2CL stock?

The intrinsic value for BridgeBio Pharma Inc (2CL) under the Base Case is 0.045 EUR.

Is 2CL stock undervalued or overvalued?

Compared with the current market price of 0.057 EUR, the stock appears Overvalued by 21% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett